Neurocognitive Follow-Up (FU) Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

21 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-26

Study Completion Date

2021-12-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a follow-up study of a recently completed trial (17.14.INF) evaluating the growth of pre-term infants. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Delayed Visual Maturation: Outcome and Predictive Factors

NCT04251338

Delayed Visual Maturation

COMPLETED

Neurodevelopment in Infants With Complex Congenital Heart Defects

NCT03104751

Complex Congenital Heart Defect

COMPLETED

Psychomotor Performance of Preterm Infants

NCT05930522

Psychomotor Development Impaired

COMPLETED

Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome

NCT00713635

Congenital Heart Disease

COMPLETED

Body Movements Analysis During Sleep in Very Premature Infants

NCT03432182

Sleep

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a follow-up study of a recently completed multi-center, prospective, single-arm, open-label interventional trial (17.14.INF - Alprem RTF: NCT03728764) evaluating the growth of pre-term infants receiving a two-stage PTF feeding system while in the neonatal care unit and continuing until 30 days post-discharge.

Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA). The timing of the cognitive assessments aligns with routine check-up visits and reflect the period at which developmental delays may first become evident.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Developmental Delay

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Alprem RTF Brain Follow-up

Neurocognitive Follow-up of children previously having participated in the Alprem RTF study

Neurocognitive Follow-up

Intervention Type OTHER

Standard clinical and parent-reported outcomes on cognitive development, temperament and overall health conditions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.